Stocks and InvestingStocks and Investing
Tue, October 30, 2018
Mon, October 29, 2018
Fri, October 26, 2018
Thu, October 25, 2018
Wed, October 24, 2018

Cory Kasimov Maintained (BIIB) at Buy with Decreased Target to $436 on, Oct 24th, 2018


Published on 2024-10-26 09:51:22 - WOPRAI, Cory Kasimov
  Print publication without navigation


Cory Kasimov of JP Morgan, Maintained "Biogen Inc." (BIIB) at Buy with Decreased Target from $445 to $436 on, Oct 24th, 2018.

Cory has made no other calls on BIIB in the last 4 months.



There are 9 other peers that have a rating on BIIB. Out of the 9 peers that are also analyzing BIIB, 3 agree with Cory's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Aaron Gal of "Bernstein" Downgraded from Buy to Hold on, Friday, October 19th, 2018
  • Geoff Meacham of "Barclays" Maintained at Hold with Increased Target to $320 on, Wednesday, July 25th, 2018
  • Brian Skorney of "Baird" Maintained at Hold with Increased Target to $348 on, Wednesday, July 25th, 2018


These are the ratings of the 6 analyists that currently disagree with Cory


  • Alethia Young of "Cantor Fitzgerald" Initiated at Buy and Held Target at $400 on, Monday, October 1st, 2018
  • Thomas Shrader of "Stifel" Initiated at Strong Buy and Held Target at $394 on, Tuesday, August 7th, 2018
  • Carter Gould of "UBS" Maintained at Strong Buy with Increased Target to $395 on, Thursday, July 26th, 2018
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $392 on, Wednesday, July 25th, 2018
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $396 on, Monday, July 23rd, 2018
  • Robyn Karnauskas of "Citigroup" Upgraded from Hold to Strong Buy and Held Target at $371 on, Friday, July 6th, 2018